SMOC1 and Cognitive impairment: SMOC1 (protein for AQALEQAK peptide), which is related to the extracellular matrix and strongly correlated with global AD pathology in brain63, has shown the ability to discriminate between AD and non-AD cognitive impairment (specificity for AD) and to predict levels of CSF Aβ42, tTau, and pTau58.